These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 17515507)
1. Association of nuclear, cytoplasmic expression of galectin-3 with beta-catenin/Wnt-pathway activation in thyroid carcinoma. Weinberger PM; Adam BL; Gourin CG; Moretz WH; Bollag RJ; Wang BY; Liu Z; Lee JR; Terris DJ Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):503-10. PubMed ID: 17515507 [TBL] [Abstract][Full Text] [Related]
2. Differential expression of galectin-3, beta-catenin, and cyclin D1 in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands. Ferrazzo KL; Neto MM; dos Santos E; dos Santos Pinto D; de Sousa SO J Oral Pathol Med; 2009 Oct; 38(9):701-7. PubMed ID: 19659475 [TBL] [Abstract][Full Text] [Related]
3. Aberrant nuclear localization of beta-catenin without genetic alterations in beta-catenin or Axin genes in esophageal cancer. Kudo J; Nishiwaki T; Haruki N; Ishiguro H; Shibata Y; Terashita Y; Sugiura H; Shinoda N; Kimura M; Kuwabara Y; Fujii Y World J Surg Oncol; 2007 Feb; 5():21. PubMed ID: 17309796 [TBL] [Abstract][Full Text] [Related]
4. Expression of Wnt-signaling pathway proteins in intraductal papillary mucinous neoplasms of the pancreas: a tissue microarray analysis. Chetty R; Serra S; Salahshor S; Alsaad K; Shih W; Blaszyk H; Woodgett JR; Tsao MS Hum Pathol; 2006 Feb; 37(2):212-7. PubMed ID: 16426922 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis. Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500 [TBL] [Abstract][Full Text] [Related]
6. beta-Catenin nuclear accumulation in head and neck mucoepidermoid carcinoma: its role in cyclin D1 overexpression and tumor progression. Shiratsuchi H; Nakashima T; Hirakawa N; Toh S; Nakagawa T; Saito T; Tsuneyoshi M; Komune S Head Neck; 2007 Jun; 29(6):577-84. PubMed ID: 17315172 [TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with tumour size and aberrant beta-catenin expression. Lantsov D; Meirmanov S; Nakashima M; Kondo H; Saenko V; Naruke Y; Namba H; Ito M; Abrosimov A; Lushnikov E; Sekine I; Yamashita Sh Histopathology; 2005 Sep; 47(3):248-56. PubMed ID: 16115225 [TBL] [Abstract][Full Text] [Related]
8. Expression and significance of adenomatous polyposis coli, beta-catenin, E-cadherin and cyclin D1 in esophageal squamous cell carcinoma assessed by tissue microarray. Peng H; Zhong XY; Liu KP; Li SM Ai Zheng; 2009 Jan; 28(1):38-41. PubMed ID: 19448414 [TBL] [Abstract][Full Text] [Related]
9. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation. Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue. Cvejic D; Savin S; Paunovic I; Tatic S; Havelka M; Sinadinovic J Anticancer Res; 1998; 18(4A):2637-41. PubMed ID: 9703921 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast. Prasad CP; Mirza S; Sharma G; Prashad R; DattaGupta S; Rath G; Ralhan R Life Sci; 2008 Aug; 83(9-10):318-25. PubMed ID: 18662704 [TBL] [Abstract][Full Text] [Related]
12. [Role of Wnt/beta-catenin signaling transduction pathway in rat hepatocarcinogenesis]. Wang QM; Li X; Jia LQ; Yang KM; Zhou HY; Yang HJ Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):454-7. PubMed ID: 16806007 [TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor expression in serous ovarian carcinoma: an immunohistochemical study with galectin-3 and cyclin D1 and outcome. Brustmann H Int J Gynecol Pathol; 2008 Jul; 27(3):380-9. PubMed ID: 18580315 [TBL] [Abstract][Full Text] [Related]
14. Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma. Kim YD; Park CH; Kim HS; Choi SK; Rew JS; Kim DY; Koh YS; Jeung KW; Lee KH; Lee JS; Juhng SW; Lee JH J Gastroenterol Hepatol; 2008 Jan; 23(1):110-8. PubMed ID: 18171349 [TBL] [Abstract][Full Text] [Related]
15. Activation of the Wnt/beta-catenin signaling pathway during oral carcinogenesis process is not influenced by the absence of galectin-3 in mice. Sant'ana JM; Chammas R; Liu FT; Nonogaki S; Cardoso SV; Loyola AM; de Faria PR Anticancer Res; 2011 Sep; 31(9):2805-11. PubMed ID: 21868523 [TBL] [Abstract][Full Text] [Related]
16. Galectin-3 is a presurgical marker of human thyroid carcinoma. Orlandi F; Saggiorato E; Pivano G; Puligheddu B; Termine A; Cappia S; De Giuli P; Angeli A Cancer Res; 1998 Jul; 58(14):3015-20. PubMed ID: 9679965 [TBL] [Abstract][Full Text] [Related]
17. Nuclear beta-catenin correlates with cyclin D1 expression in spindle and pleomorphic sarcomas but not in synovial sarcoma. Saito T; Oda Y; Yamamoto H; Kawaguchi K; Tanaka K; Matsuda S; Iwamoto Y; Tsuneyoshi M Hum Pathol; 2006 Jun; 37(6):689-97. PubMed ID: 16733209 [TBL] [Abstract][Full Text] [Related]
18. Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas. Sareddy GR; Panigrahi M; Challa S; Mahadevan A; Babu PP Neurochem Int; 2009 Sep; 55(5):307-17. PubMed ID: 19576519 [TBL] [Abstract][Full Text] [Related]
19. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Inohara H; Honjo Y; Yoshii T; Akahani S; Yoshida J; Hattori K; Okamoto S; Sawada T; Raz A; Kubo T Cancer; 1999 Jun; 85(11):2475-84. PubMed ID: 10357421 [TBL] [Abstract][Full Text] [Related]
20. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Shan BE; Wang MX; Li RQ Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]